Only one out of 10 manufacturers across sectors has deployed artificial intelligence at scale, while most of them focus their ...

EY-Parthenon says US needs $13.7 trillion to decouple from China over 25 years. Here's what the astronomical price tag means ...

A recently released Warehouse Specialists Inc, LLC survey of 306 supply chain, operations, and logistics leaders at U.S.

Buy GEV. Morgan Stanley expects a post-earnings bounce on July 22 driven by stronger-than-expected gas turbine contract wins ...

Texas is spearheading a national drive to reshore manufacturing, particularly in solar panels and large-scale batteries, ...

A fixed 15.5% manufacturer rebate on patented branded drugs replaces a proposed variable, expenditure-linked mechanism after coordinated industry pressure and threats to curtail German investment and ...

Apple will spend more than $30bn with Broadcom to make 15 billion US chips, its largest American manufacturing pledge, with a $1.5bn Fort Collins plant.

Section 232 introduces a staged tariff regime: 100% default for patented drugs/APIs/KSMs, reduced 20% with approved onshoring plans, and temporary 0% if paired with MFN pricing until 2029. Deadlines ...

The reshoring trade has moved from political talking point to capital expenditure line item, and the funds that own the picks ...

China’s October 2025 expansion of rare earth export controls continues to ripple through equity markets eight months later.

All three of these rare-earth metal stocks are set to benefit from reshoring, so the real question is how much risk are you ...

Ryan Last, senior associate at Troutman Pepper Locke explains how existing regulations and potential foreign countermeasures have a significant impact on reshoring efforts. In April of this year, ...